Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Graybug and CalciMedica Enter into Definitive Merger Agreement

Tuesday, November 22, 2022

Graybug Vision Inc and CalciMedica Inc announced that they have entered into a definitive merger agreement to combine the companies in an allstock transaction The combined company will focus on further developing CalciMedicas lead product candidate A...

Cambrex to Acquire Snapdragon Chemistry, a Leader in Continuous Flow API Development Services

Tuesday, November 22, 2022

Cambrex a leading global contract development and manufacturing organization CDMO providing drug substance drug product and analytical services across the entire drug lifecycle today announced that it has entered into a definitive agreement to acquir...

Regeneron and CytomX Announce Strategic Research Collaboration in the Field of Conditional Bispecific Therapeutics for the Treatment of Cancer

Friday, November 18, 2022

Regeneron Pharmaceuticals Inc and CytomX Therapeutics Inc announced a collaboration and licensing agreement to create conditionallyactivated investigational bispecific cancer therapies utilizing CytomXs Probody therapeutic platform and Regenerons Vel...

Iveric Bio Announces FDA Has Granted Breakthrough Therapy Designation for Avacincaptad Pegol for Geographic Atrophy

Friday, November 18, 2022

IVERIC bio Inc announced that the US Food and Drug Administration FDA has granted Breakthrough Therapy designation for avacincaptad pegol ACP also known as Zimura a novel investigational complement C inhibitor for the treatment of geographic atrophy...

Roche receives U.S. FDA Emergency Use Authorization for its high-throughput test to detect monkeypox virus

Thursday, November 17, 2022

Roche announced that the US Food and Drug Administration FDA granted Emergency Use Authorization EUA for cobas MPXV for use on the cobas Systems The test is a real time PCR test for the qualitative detection of DNA from monkeypox virus MPXV in lesio...

Alexion, AstraZeneca Rare Disease, Completes Acquisition of LogicBio® Therapeutics

Thursday, November 17, 2022

Alexion AstraZeneca Rare Disease today announced the completion of its acquisition of LogicBio Therapeutics Inc a pioneering genomic medicine company The acquisition creates an opportunity to accelerate Alexions growth in genomic medicines through un...

Ferring Pharmaceuticals and Gubra announce collaboration within inflammatory bowel disease (IBD)

Wednesday, November 16, 2022

Ferring Pharmaceuticals and Gubra entered into a collaboration agreement to further develop and characterize preclinical animal models of inflammatory bowel disease IBD The collaboration aims to advance our early pipeline of targets in intestinal inf...

Simcere and Idorsia enter into a licensing agreement for daridorexant in China

Wednesday, November 16, 2022

Simcere Pharmaceutical Group Ltd an innovation and RDdriven pharmaceutical companyand Idorsia Ltd specialized in the discovery development and commercialization of small molecules to transform the horizon of therapeutic options announced today that t...

Teva Announces Unique Collaboration with Rimidi to Expand the Reach of its Respiratory Digital Health Platform

Tuesday, November 15, 2022

Teva Pharmaceuticals a US affiliate of Teva Pharmaceutical Industries Ltd announced a new collaboration with Rimidi a leading clinical management platform designed to optimize clinical workflows enhance patient experiences and achieve quality objecti...

Relief Therapeutics Holding SA and NRx Pharmaceuticals, Inc. Announce Execution of Definitive Settlement Agreements

Tuesday, November 15, 2022

Relief Therapeutics Holding SA and NRx Pharmaceuticals Inc today announced that they have entered into definitive settlement agreements to resolve their pending litigation As part of the settlement at a closing to be held within the next days i NRx...